US Stocks
/
Immunovant, Inc. Share Price
Immunovant, Inc. Share Price

Immunovant, Inc. Share Price

NASDAQ: IMVT | Mid Cap
$37.66
+$1.29 (3.55%) Last updated on 18 Sep, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Immunovant, Inc. Stock Performance

Open
$36.92
Prev. Close
$36.37
Circuit Range
N/A
Day Range
$36.59 - $37.61
Year Range
$14.59 - $45.26
Volume
47,273
Average Traded
$37.07

Immunovant, Inc. Share Price Today

As of 18 September 2026, Immunovant, Inc.'s share price is $37.66. The stock opened at $36.92, compared to its previous close of $36.37. During today's trading session, Immunovant, Inc.'s share price traded between $36.59 and $37.61, with an average price of $37.10. Over the past 52 weeks, the stock has recorded a high of $45.26 and a low of $14.59. In terms of performance, Immunovant, Inc.'s share price has risen by 51.49% over the last six months and is up 133.41% on a year-on-year basis.

Immunovant, Inc. Share Price Chart

$36.59$37.61
L
Show Current Price
H

Immunovant, Inc. Stock Fundamentals & Key Indicators

Market Cap
$5.71B
PE Ratio (TTM)
-13.79
Dividend Yield
N/A
EPS (TTM)
$-2.73
Revenue (TTM)
N/A
Return On Equity (TTM)
-58.50%
Profit Margin
N/A
Debt to Equity
0.10
Quarterly Earnings Growth YoY
0.44%

Immunovant, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsDec 2023Jun 2024Sep 2024Dec 2024Jun 2025Sep 2025Dec 2025
RevenueN/AN/AN/AN/AN/AN/AN/A
Net Profit-$51.42M-$87.15M-$109.12M-$111.12M-$120.61M-$126.50M-$110.64M
Net Profit MarginN/AN/AN/AN/AN/AN/AN/A
Income ChangeN/A-69.49%-25.21%-1.84%-8.54%-4.88%12.54%

Immunovant, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
RevenueN/AN/AN/AN/A
Net Profit-$156.73M-$210.96M-$259.34M-$413.84M
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-34.60%-22.93%-59.58%

About Immunovant, Inc.

Immunovant, Inc., a clinical-stage immunology company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops IMVT-1402 for graves' disease, rheumatoid arthritis, myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, cutaneous lupus erythematosus disease, and sjögren's disease; and batoclimab for graves' disease and thyroid eye disease. The company has a license agreement with HanAll Biopharma Co., Ltd. for the rights of intellectual property relating to IMVT-1402 and batoclimab. Immunovant, Inc. was founded in 2018 and is based in New York, New York. Immunovant, Inc. is a subsidiary of Roivant Sciences Ltd.

Immunovant, Inc. Historical Returns

MonthOpenCloseChange %
Sep 2026
$40.52
$37.58
-14.23%
Aug 2026
$38.32
$43.81
+13.39%
Jul 2026
$38.55
$38.64
+0.23%
Jun 2026
$32.75
$38.55
+15.87%
May 2026
$27.41
$33.27
+22.54%
Apr 2026
$25.04
$27.15
+9.21%
Mar 2026
$27.11
$24.86
-10.41%
Feb 2026
$25.80
$27.75
+6.63%
Jan 2026
$25.68
$26.02
+2.42%
Dec 2025
$23.86
$25.41
+5.13%
Nov 2025
$24.64
$24.17
-2.09%
Oct 2025
$16.18
$24.68
+52.99%

IMVT Share Price FAQs

What is Immunovant, Inc. share price today?

chevron-up
Immunovant, Inc. share price today is $37.66 as on September 18, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Immunovant, Inc. stock?

chevron-up
The 52 week high of Immunovant, Inc. stock is $45.26, while the 52 week low is $14.59 as of 18 Sep '26.

What is IMVT's market capitalisation today?

chevron-up
IMVT market capitalisation is $5.71B as of September 18, 2026, at 2:47 pm IST.

What is IMVT's net income for the last quarter?

chevron-up
IMVT's net income for the last quarter is -0.11B USD.

What is the 5 year returns of IMVT?

chevron-up
The 5 year returns of IMVT is 333.37% as on 18 Sep '26.

What is the high & low stock price of IMVT today?

chevron-up
IMVT stock price hit a high of $37.61 and low of $36.59 as of 18 Sep '26.

Can I buy IMVT shares in India?

chevron-up
Yes. You can buy IMVT in India by opening an international trading account.